Takeda Pharmaceutical マネジメント
マネジメント 基準チェック /24
Takeda Pharmaceuticalの CEO はChristophe Weberで、 Jun2014年に任命され、 の在任期間は 10.42年です。 の年間総報酬は¥ 2.08Bで、 15.2%給与と84.8%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.05%を直接所有しており、その価値は¥ 3.23B 。経営陣と取締役会の平均在任期間はそれぞれ7.1年と8.4年です。
主要情報
Christophe Weber
最高経営責任者
JP¥2.1b
報酬総額
| CEO給与比率 | 15.2% |
| CEO在任期間 | 10.4yrs |
| CEOの所有権 | 0.05% |
| 経営陣の平均在職期間 | 7.1yrs |
| 取締役会の平均在任期間 | 8.4yrs |
経営陣の近況
Recent updates
Results: Takeda Pharmaceutical Company Limited Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 04
Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00
Sep 24Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E
Sep 20Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's
Aug 08Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 02Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00
Jul 25Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's
Jul 11Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year
Jun 30Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt
Jun 11Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings
May 21Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next
May 12Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00
Mar 28Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00
Mar 13Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00
Feb 26CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | JP¥290b |
| Jun 30 2024 | n/a | n/a | JP¥150b |
| Mar 31 2024 | JP¥2b | JP¥317m | JP¥144b |
| Dec 31 2023 | n/a | n/a | JP¥178b |
| Sep 30 2023 | n/a | n/a | JP¥192b |
| Jun 30 2023 | n/a | n/a | JP¥301b |
| Mar 31 2023 | JP¥2b | JP¥295m | JP¥317b |
| Dec 31 2022 | n/a | n/a | JP¥275b |
| Sep 30 2022 | n/a | n/a | JP¥213b |
| Jun 30 2022 | n/a | n/a | JP¥197b |
| Mar 31 2022 | JP¥2b | JP¥281m | JP¥230b |
| Dec 31 2021 | n/a | n/a | JP¥439b |
| Sep 30 2021 | n/a | n/a | JP¥473b |
| Jun 30 2021 | n/a | n/a | JP¥431b |
| Mar 31 2021 | JP¥2b | JP¥267m | JP¥376b |
| Dec 31 2020 | n/a | n/a | JP¥181b |
| Sep 30 2020 | n/a | n/a | JP¥56b |
| Jun 30 2020 | n/a | n/a | JP¥120b |
| Mar 31 2020 | JP¥2b | JP¥273m | JP¥44b |
| Dec 31 2019 | n/a | n/a | JP¥13b |
| Sep 30 2019 | n/a | n/a | JP¥83b |
| Jun 30 2019 | n/a | n/a | JP¥64b |
| Mar 31 2019 | JP¥2b | JP¥269m | JP¥135b |
| Dec 31 2018 | n/a | n/a | JP¥110b |
| Sep 30 2018 | n/a | n/a | JP¥141b |
| Jun 30 2018 | n/a | n/a | JP¥120b |
| Mar 31 2018 | JP¥1b | JP¥254m | JP¥187b |
報酬と市場: Christopheの 総報酬 ($USD 13.45M ) は、 JP市場 ($USD 1.38M ) の同規模の企業の平均を上回っています。
報酬と収益: Christopheの報酬は過去 1 年間で 20% 以上増加しました。
CEO（最高経営責任者
Christophe Weber (58 yo)
10.4yrs
在職期間
JP¥2,083,000,000
報酬
Mr. Christophe Weber has been the President and Chief Executive Officer of Takeda Pharmaceutical Company Limited since June 27, 2014 and April 2015 respectively and served as its Chief Operating Officer fr...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 10.4yrs | JP¥2.08b | 0.050% ¥ 3.2b | |
| Chair of Management Board | no data | データなし | データなし | |
| CFO & Director | less than a year | データなし | 0.00083% ¥ 54.1m | |
| Member of Management Board | no data | データなし | データなし | |
| Member of Management Board and Head of R&D Global Science & Biomedical Policy | no data | データなし | データなし | |
| Chief Accounting Officer & Corporate Controller | no data | データなし | データなし | |
| Senior Vice President of Corporate Finance & Controlling Department | 11.7yrs | データなし | データなし | |
| Chief Data & Technology Officer | 2.8yrs | データなし | データなし | |
| Global Head of Investor Relations & Global Finance | 4.2yrs | データなし | データなし | |
| Global General Counsel | 10.1yrs | データなし | データなし | |
| Chief Ethics & Compliance Officer | 10.1yrs | データなし | データなし | |
| Chief Human Resources Officer | 3.8yrs | データなし | データなし |
7.1yrs
平均在職期間
51.5yo
平均年齢
経験豊富な経営陣: 4502の経営陣は経験豊富で経験豊富です（平均在職期間は7.1年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 10.4yrs | JP¥2.08b | 0.050% ¥ 3.2b | |
| CFO & Director | no data | データなし | 0.00083% ¥ 54.1m | |
| President of Research & Development and Representative Director | 9.4yrs | JP¥972.00m | 0.0087% ¥ 569.2m | |
| Independent External Director | 2.4yrs | JP¥32.00m | データなし | |
| Independent External Director | 5.8yrs | JP¥44.00m | 0.00026% ¥ 17.0m | |
| Independent External Director | 8.4yrs | JP¥49.00m | 0.00016% ¥ 10.4m | |
| Independent External Director | 8.4yrs | JP¥40.00m | 0.00079% ¥ 51.5m | |
| Independent External Director | 5.8yrs | JP¥44.00m | 0.000070% ¥ 4.6m | |
| Independent External Director | 5.4yrs | JP¥38.00m | データなし | |
| Independent External Director | 8.4yrs | JP¥46.00m | データなし | |
| Independent External Chair | 3.4yrs | JP¥43.00m | 0.000020% ¥ 1.3m | |
| Independent External Director | 8.4yrs | JP¥43.00m | 0.00063% ¥ 41.1m |
8.4yrs
平均在職期間
66.5yo
平均年齢
経験豊富なボード: 4502の 取締役会 は 経験豊富 であると考えられます ( 8.4年の平均在任期間)。